Pharmacokinetic Distribution of 67Cu(II)2[3,5-Diisopropyl(Carboxy- 14C)Salicylate]4 Among Murine Tissues

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|11|22|3007-3015

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.11, Iss.22, 2004-11, pp. : 3007-3015

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological and haematological results of rat skin burn injury treatment with Cu(II) 2 (3,5-diisopropylsalicylate) 4

By Malakyan Margarita H.   Bajinyan Sergey A.   Abrahamyan Armenuhi K.   Petrosyan Zhasmena H.   Harutyunyan Nektar K.   Badiryan Vardush A.   Sorenson John R.J.  

Inflammopharmacology, Vol. 12, Iss. 4, 2004-12 ,pp. : 321-351

VSP

Access to resources Recommend Favorite

Pharmacokinetic Modeling of Disposition and Time-Course Studies With [14C]Atrazine

By McMullin Tami   Brzezicki Jill   Cranmer Brian   Tessari John   Andersen Melvin  

Journal of Toxicology and Environmental Health, Vol. 66, Iss. 10, 2003-01 ,pp. : 941-964

Taylor & Francis Ltd

Access to resources Recommend Favorite

Absorption, Distribution, Metabolism and Excretion of [14C]Dexlansoprazole in Healthy Male Subjects

By Grabowski Brian   Lee Ronald D.  

Clinical Drug Investigation, Vol. 32, Iss. 5, 2012-05 ,pp. : 319-332

Adis International

Access to resources Recommend Favorite

3-Hydroxy-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9H)-ones as new HIV-1 integrase inhibitors WO2011046873 A1

By Cotelle Philippe  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 11, 2011-11 ,pp. : 1799-1804

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic behavior of 4-nonylphenol in humans

By Muller S.   Schmid P.   Schlatter C.  

Environmental Toxicology and Pharmacology, Vol. 5, Iss. 4, 1998-06 ,pp. : 257-265

Elsevier

Access to resources Recommend Favorite